⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENSC News
Ensysce Biosciences, Inc. Common Stock
Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
accessnewswire.com
ENSC
Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
accessnewswire.com
ENSC
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
accessnewswire.com
ENSC
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSC
Form 8-K
sec.gov
ENSC
Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSC
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
accessnewswire.com
ENSC
Form 8-K/A
sec.gov
ENSC